Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker

H.R. 1051 · Where this bill is now

In committee

Introduced in the House, sent to the Committee on Energy and Commerce, Feb 6, 2025

119th Congress
1st SessionH. R. 1051

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.

In the HouseNo vote yet

Sponsor: Rep. Nikki Budzinski (D-IL-13) · Introduced Feb 6, 2025 · Health · 1 version of the text

Read the full billOfficial record on Congress.gov ↗

Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Feb 6, 2025: “Referred to the House Committee on Energy and Commerce.”

Sections

Sections · 1
H.R. 1051: To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes. — Bill Status, Votes and Text · Public Law Tracker